NextGen started trading in 2000. It provides equipment, services and reagents used to understand and enhance the role of proteins in diagnosis and drug discovery. NextGen joined Aim on 30 December 2005. It raised £1.9m after expenses through the placing of 40,000 units (containing two shares and one warrant enabling the holder to subscribe 3p for an additional share before the end of 2008) at 6p each. That is equivalent to 3p a share.